Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
Perioperative immunonutrition in gastric cancer patients can reduce perioperative morbidity
and may improve quality of their life. Patients with gastric cancer will be divided into four
groups depending on the type of artificial nutrition. Group I (enteral feeding) and II
(enteral feeding and parenteral nutrition with glutamine) will be administered nutritional
therapy during the postoperative period, group III (oral arginine) and IV (parenteral
immunonutrition) patients will be treated nutritionally both prior to and after the surgery.
The lymphocytes and their subpopulations, interleukin IL-1B,-6,-23, and the phagocytic, and
bactericidal activity of blood platelets will be determined before and after nutritional
therapy.